Francesco Perrone

Francesco Perrone at the 1960 Olympics Francesco Perrone (3 December 1930 – 27 April 2020) was an Italian long-distance runner. He competed in the marathon at the 1960 Summer Olympics. Perrone was an athlete of the Gruppo Sportivo Fiamme Oro. Perrone died from COVID-19 during the pandemic in Italy on 27 April 2020 at the age of 89. Provided by Wikipedia
Showing 1 - 20 results of 28 for search 'Francesco Perrone', query time: 0.07s Refine Results
  1. 1
    FINANCIAL TOXICITY: AN EMERGING PROBLEM FOR CANCER PATIENTS

    FINANCIAL TOXICITY: AN EMERGING PROBLEM FOR CANCER PATIENTS by Francesco Perrone

    Published 2024-12-01
    Get full text
    Article
  2. 2
    cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation?

    cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation? by Nicola Normanno, Antonella De Luca, Francesco Perrone

    Published 2020-07-01
    Get full text
    Article
  3. 3
    A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan

    A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19... by Paolo Chiodini, Laura Arenare, Maria Carmela Piccirillo, Francesco Perrone, Ciro Gallo

    Published 2020-12-01
    Get full text
    Article
  4. 4
    Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials

    Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials by Raimondo Di Liello, Maria Carmela Piccirillo, Laura Arenare, Piera Gargiulo, Clorinda Schettino, Adriano Gravina, Francesco Perrone

    Published 2021-11-01
    Get full text
    Article
  5. 5
    The opportunity of patient-journey studies for academic clinical research in oncology

    The opportunity of patient-journey studies for academic clinical research in oncology by Raimondo Di Liello, Ciro Gallo, Francesco Perrone, Laura Arenare, Paolo Chiodini, Maria Carmela Piccirillo, Piera Gargiulo, Lorenzo Guizzaro

    Published 2021-09-01
    Get full text
    Article
  6. 6
    Designing, producing and exemplifying videos to support reflection and metacognition for in-service teachers training

    Designing, producing and exemplifying videos to support reflection and metacognition for in-service teachers training by Valentina Toci, Loredana Camizzi, Serena Goracci, Rachele Borgi, Francesca De Santis, Laura Coscia, Francesco Perrone, Maria Elisabetta Cigognini, Maria Chiara Pettenati

    Published 2015-05-01
    Get full text
    Article
  7. 7
    The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review

    The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review by Antonio Addis, Laura Amato, Fabio Cruciani, Rosella Saulle, Franco De Crescenzo, Franco De Crescenzo, Zuzana Mitrova, Simona Vecchi, Francesco Perrone, Marina Davoli

    Published 2021-10-01
    Get full text
    Article
  8. 8
    Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy

    Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy by Bishal Gyawali, Francesco Barone-Adesi, Francesco Perrone, Francesco Trotta, Immacolata Esposito, Ranadhir Punreddy, Roberto Da Cas, Giuseppe Traversa, Nello Martini, Antonio Addis

    Published 2019-12-01
    Get full text
    Article
  9. 9
    Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy

    Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy by Ernesta Cavalcanti, Vittoria Barchiesi, Dionigio Cerasuolo, Flaviano Di Paola, Monica Cantile, Sabrina Chiara Cecere, Sandro Pignata, Alessandro Morabito, Raffaele Costanzo, Massimo Di Maio, Francesco Perrone

    Published 2016-01-01
    Get full text
    Article
  10. 10
    Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

    Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-B... by Bruno Vincenzi, Massimo Di Maio, Marianna Silletta, Loretta D'Onofrio, Chiara Spoto, Maria Carmela Piccirillo, Gennaro Daniele, Francesca Comito, Eliana Maci, Giuseppe Bronte, Antonio Russo, Daniele Santini, Francesco Perrone, Giuseppe Tonini

    Published 2015-01-01
    Get full text
    Article
  11. 11

    Title not available by Giovanni Apolone, Andrea Ardizzoni, Giuliano Buzzetti, Mario Alberto Clerico, Pierfranco Conte, Filippo de Braud, Francesco De Lorenzo, Maria Gabriella Ferrandina, Armando Genazzani, Stefania Gori, Michele Maio, Mauro Patroncini, Francesco Perrone, Giovanni Scambia, Giovanna Scroccaro

    Published 2019-06-01
    Get full text
    Article
  12. 12
    Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol

    Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol by Diana Giannarelli, Fabio Efficace, Vincenzo Montesarchio, Silvia Riva, Jane Bryce, Francesco De Lorenzo, Laura Del Campo, Massimo Di Maio, Luciano Frontini, Lara Gitto, Elisabetta Iannelli, Claudio Jommi, Francesca Traclò, Concetta Maria Vaccaro, Ciro Gallo, Francesco Perrone

    Published 2019-09-01
    Get full text
    Article
  13. 13
    Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review

    Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review by Matteo Lambertini, Filippo Pietrantonio, Dario Trapani, Francesco Perrone, Rossana Berardi, Saverio Cinieri, Chiara Cassani, Amelia Barcellini, Filippo Ghelardi, Alberto Giovanni Leone, Stefania Bonadonna, Marianna Sirico, Barbara Tagliaferri, Stefano Maccarone, Davide Dalu, Lorenzo Ruggieri, Simone Nardin, Nicla La Verde

    Published 2024-07-01
    Get full text
    Article
  14. 14
    Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience

    Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience by Daniela Califano, Daniela Russo, Giosuè Scognamiglio, Nunzia Simona Losito, Anna Spina, Anna Maria Bello, Anna Capiluongo, Francesca Galdiero, Rossella De Cecio, Simona Bevilacqua, Piera Gargiulo, Edoardo Marchesi, Silvana Canevari, Francesco Perrone, Gennaro Daniele, Loris De Cecco, Delia Mezzanzanica, Sandro Pignata

    Published 2020-04-01
    Get full text
    Article
  15. 15
    Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study

    Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study by Raimondo Di Liello, Massimo Di Maio, Francesco Perrone, Fabio Turco, Alessandro Rossi, Piera Gargiulo, Andrea Caglio, Valentina Tuninetti, Eleonora Ghisoni, Laura Marandino, Federica Trastu, Pasquale Lombardi, Annapaola Mariniello, Maria Lucia Reale, Giacomo Aimar, Marco Audisio, Maristella Bungaro, Teresa Gamba, Chiara Paratore

    Published 2023-08-01
    Get full text
    Article
  16. 16
    Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology.

    Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology. by Giacomo Pascarella, Arturo Capasso, Antonio Nardone, Maria Triassi, Sandro Pignata, Laura Arenare, Paolo Ascierto, Marcello Curvietto, Piera Maiolino, Roberta D'Aniello, Agnese Montanino, Francesca Laudato, Gianfranco De Feo, Gerardo Botti, Francesco Perrone, Antonella Petrillo, Ernesta Cavalcanti, Secondo Lastoria, Nicola Maurea, Alessandro Morabito

    Published 2019-01-01
    Get full text
    Article
  17. 17
    Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations

    Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations by Alberto Giovanni Leone, Raffaella Casolino, Dario Trapani, Rosalba Miceli, Massimo Massagrande, Federica Morano, Nicla La Verde, Davide Dalu, Rossana Berardi, Silvia Marsoni, Matteo Lambertini, Bianca Iula, Eva Carieri, Manlio Converti, Massimo Di Maio, Giordano Domenico Beretta, Francesco Perrone, Filippo Pietrantonio, Saverio Cinieri

    Published 2023-11-01
    Get full text
    Article
  18. 18
    Corrigendum to “Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study” [The Lancet Regional Health – Europe 41 (2024) 100912]

    Corrigendum to “Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study” [The Lancet R... by Maria Lucia Iacovino, Simone Celant, Luca Tomassini, Laura Arenare, Andrea Caglio, Andrea Canciello, Flavio Salerno, Pier Paolo Olimpieri, Susanna Di Segni, Antonella Sferrazza, Maria Carmela Piccirillo, Giordano Domenico Beretta, Carmine Pinto, Livio Blasi, Saverio Cinieri, Luigi Cavanna, Massimo Di Maio, Pierluigi Russo, Francesco Perrone

    Published 2024-07-01
    Get full text
    Article
  19. 19
    Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab

    Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab by Marina Fabbi, Delfina Costa, Daniela Russo, Laura Arenare, Gabriele Gaggero, Simona Signoriello, Giovanni Scambia, Carmela Pisano, Nicoletta Colombo, Nunzia Simona Losito, Gilberto Filaci, Anna Spina, Daniela Califano, Giosuè Scognamiglio, Angiolo Gadducci, Delia Mezzanzanica, Marina Bagnoli, Silvano Ferrini, Vincenzo Canzonieri, Paolo Chiodini, Francesco Perrone, Sandro Pignata

    Published 2022-08-01
    Get full text
    Article
  20. 20
    Time spent for activation of non-profit studies in oncology in Italy.

    Time spent for activation of non-profit studies in oncology in Italy. by Gianfranco De Feo, Simona Signoriello, Jane C Bryce, Antonia Del Giudice, Giuliana Canzanella, Federika Crudele, Fiorella Romano, Giovanni de Matteis, Manuela Florio, Fabiano Falasconi, Alfonso Savio, Pasqualina Giordano, Gennaro Daniele, Mario Iaccarino, Maria Carmela Piccirillo, Massimo Di Maio, Alessandro Morabito, Ciro Gallo, Francesco Perrone

    Published 2010-01-01
    Get full text
    Article

Search Tools: